This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2018-03-14PC DrugAllergySubstance Call Minutes"

From HL7Wiki
Jump to navigation Jump to search
 
(11 intermediate revisions by the same user not shown)
Line 98: Line 98:
 
'''Minutes/Conclusions Reached:'''<br/>
 
'''Minutes/Conclusions Reached:'''<br/>
 
# We will continue our meetings at the biweekly Wednesday time until the agenda items are resolved.
 
# We will continue our meetings at the biweekly Wednesday time until the agenda items are resolved.
−
 
 
# Re VSAC stewardship: Jay and Elaine to talk to HL7 HTA about appropriate path. This includes maintenance plans.
 
# Re VSAC stewardship: Jay and Elaine to talk to HL7 HTA about appropriate path. This includes maintenance plans.
−
 
 
# VSAC text in process. Note [https://www.nlm.nih.gov/vsac/support/authorguidelines/bestpractices.html  guidance] from NLM.
 
# VSAC text in process. Note [https://www.nlm.nih.gov/vsac/support/authorguidelines/bestpractices.html  guidance] from NLM.
−
 
 
# Similar value sets are published by other groups. Check for overlap.
 
# Similar value sets are published by other groups. Check for overlap.
−
 
 
# publish in VSAC, using roles (2) and text (3) defined above.
 
# publish in VSAC, using roles (2) and text (3) defined above.
−
 
 
# Document publication process steps
 
# Document publication process steps
 
## Jay finish applying changes, circulate document  
 
## Jay finish applying changes, circulate document  
 
## After VSAC publication publish, include OIDs
 
## After VSAC publication publish, include OIDs
−
 
 
# FHIR & CCDA adoption
 
# FHIR & CCDA adoption
 
## CCDA: Emma, Lisa
 
## CCDA: Emma, Lisa
Line 116: Line 110:
  
  
 +
Proposed VSAC definitions
 +
<table border="1" cellpadding="2" cellspacing="0" width="100%">
 +
<tr bgcolor=#f0f0f0>
 +
  <th>element</th>
 +
  <th>text</th>
 +
</tr>
 +
<tr>
 +
<td bgcolor=#eeeeee colspan = 2>Drug substances - reviewed 3/14</td>
 +
</tr>
 +
<tr>
 +
<td>OID</td>
 +
<td>NLM-assigned</td>
 +
</tr>
 +
<tr>
 +
<td>Name</td>
 +
<td>Common Drug Substances for Allergy and Intolerance Documentation</td>
 +
</tr>
 +
<tr>
 +
<td>Author</td>
 +
<td></td>
 +
</tr>
 +
<tr>
 +
<td>Steward</td>
 +
<td></td>
 +
</tr>
 +
<tr>
 +
<td>Clinical focus</td>
 +
<td>Documentation of a medication substance commonly suspected of causing an allergy or intolerance reaction in an individual</td>
 +
</tr>
 +
<tr>
 +
<td>Date element Scope</td>
 +
<td>Reactant element of allergy or intolerance record</td>
 +
</tr>
 +
<tr>
 +
<td>Inclusion criteria</td>
 +
<td>RxNorm substances of term type ingredient (IN) or multiple ingredient (MIN)</td>
 +
</tr>
 +
<tr>
 +
<td>Exclusion criteria</td>
 +
<td>Other RxNorm term types</td>
 +
</tr>
 +
<tr>
 +
<td bgcolor=#eeeeee colspan = 2>Drug classes - reviewed 3/14</td>
 +
</tr>
 +
<tr>
 +
<td>OID</td>
 +
<td>NLM-assigned</td>
 +
</tr>
 +
<tr>
 +
<td>Name</td>
 +
<td>Common drug classes for allergy and intolerance documentation</td>
 +
</tr>
 +
<tr>
 +
<td>Author</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Steward</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Clinical focus</td>
 +
<td>Documentation of a class of medication substances suspected of causing an allergy or intolerance reaction in an individual</td>
 +
</tr>
 +
<tr>
 +
<td>Date element Scope</td>
 +
<td>Reactant element of allergy or intolerance record</td>
 +
</tr>
 +
<tr>
 +
<td>Inclusion criteria</td>
 +
<td>NDF-RT drug classes commonly relevant to allergy or intolerance cross-reactivity</td>
 +
</tr>
 +
<tr>
 +
<td>Exclusion criteria</td>
 +
<td>NDF-RT drug classes not commonly relevant to allergy or intolerance cross-reactivity</td>
 +
</tr>
 +
<tr>
 +
<td bgcolor=#eeeeee colspan = 2>Foods</td>
 +
</tr>
 +
<tr>
 +
<td>OID</td>
 +
<td>NLM-assigned</td>
 +
</tr>
 +
<tr>
 +
<td>Name</td>
 +
<td>Common dietary substances for allergy and intolerance documentation</td>
 +
</tr>
 +
<tr>
 +
<td>Author</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Steward</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Clinical focus</td>
 +
<td>Documentation of a class of foods and dietary substances suspected of causing an allergy or intolerance reaction in an individual</td>
 +
</tr>
 +
<tr>
 +
<td>Date element Scope</td>
 +
<td>Reactant element of allergy or intolerance record</td>
 +
</tr>
 +
<tr>
 +
<td>Inclusion criteria</td>
 +
<td>SNOMED-CT dietary substances ingested by patients, both specific (e.g., strawberry) and general (e.g., crustaceans); Substances that may be either foods or drugs (e.g., ethanol)</td>
 +
</tr>
 +
<tr>
 +
<td>Exclusion criteria</td>
 +
<td>SNOMED-CT prodcuts; environmental substances; expressions asserting absence of conditions; Actual conditions caused by exposure (reactions, allergies)</td>
 +
</tr>
 +
<tr>
 +
<td bgcolor=#eeeeee colspan = 2>Environmental substances</td>
 +
</tr>
 +
<tr>
 +
<td>OID</td>
 +
<td>NLM-assigned</td>
 +
</tr>
 +
<tr>
 +
<td>Name</td>
 +
<td>Common environmental substances  for allergy and intolerance documentation</td>
 +
</tr>
 +
<tr>
 +
<td>Author</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Steward</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Clinical focus</td>
 +
<td>Documentation of environmental substances to which patients may be exposed suspected of causing an allergy or intolerance reaction in an individual</td>
 +
</tr>
 +
<tr>
 +
<td>Date element Scope</td>
 +
<td>Reactant element of allergy or intolerance record</td>
 +
</tr>
 +
<tr>
 +
<td>Inclusion criteria</td>
 +
<td>SNOMED-CT environmental substances suspected of causing reactions</td>
 +
</tr>
 +
<tr>
 +
<td>Exclusion criteria</td>
 +
<td>Drugs and foods; expressions asserting absence of conditions; Actual conditions caused by exposure (reactions, allergies)</td>
 +
</tr>
 +
<tr>
 +
<td bgcolor=#eeeeee colspan = 2>Negations</td>
 +
</tr>
 +
<tr>
 +
<td>OID</td>
 +
<td>NLM-assigned</td>
 +
</tr>
 +
<tr>
 +
<td>Name</td>
 +
<td>Common negations of substance causes for allergy for allergy and intolerance documentation</td>
 +
</tr>
 +
<tr>
 +
<td>Author</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Steward</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Clinical focus</td>
 +
<td>Refutation of associations between substances and reactions </td>
 +
</tr>
 +
<tr>
 +
<td>Date element Scope</td>
 +
<td>Reactant element of allergy or intolerance record</td>
 +
</tr>
 +
<tr>
 +
<td>Inclusion criteria</td>
 +
<td>Assertions that a substance or class of substance does not cause adverse reactions in the patient</td>
 +
</tr>
 +
<tr>
 +
<td>Exclusion criteria</td>
 +
<td>Substances; Actual conditions caused by exposure (reactions, allergies)</td>
 +
</tr>
 +
<tr>
 +
<td bgcolor=#eeeeee colspan = 2>Negations</td>
 +
</tr>
 +
<tr>
 +
<td>OID</td>
 +
<td>NLM-assigned</td>
 +
</tr>
 +
<tr>
 +
<td>Name</td>
 +
<td>Common substances for allergy and intolerance documentation</td>
 +
</tr>
 +
<tr>
 +
<td>Author</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Steward</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Clinical focus</td>
 +
<td>Documentation of substances suspected of causing an allergy or intolerance reaction in an individual</td>
 +
</tr>
 +
<tr>
 +
<td>Date element Scope</td>
 +
<td>Reactant element of allergy or intolerance record</td>
 +
</tr>
 +
<tr>
 +
<td>Inclusion criteria</td>
 +
<td>Specific or general substances to which a patient may be exposed and which may be suspected of causing an adverse reaction</td>
 +
</tr>
 +
<tr>
 +
<td>Exclusion criteria</td>
 +
<td>Actual conditions caused by exposure (reactions, allergies); negations of these conditions</td>
 +
</tr>
 +
<tr>
 +
<td bgcolor=#eeeeee colspan = 2>Negations</td>
 +
</tr>
 +
<tr>
 +
<td>OID</td>
 +
<td>NLM-assigned</td>
 +
</tr>
 +
<tr>
 +
<td>Name</td>
 +
<td>Common values for allergy and intolerance documentation</td>
 +
</tr>
 +
<tr>
 +
<td>Author</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Steward</td>
 +
<td>TBD</td>
 +
</tr>
 +
<tr>
 +
<td>Clinical focus</td>
 +
<td>Documentation of substances suspected of (or not suspected of) causing an allergy or intolerance reaction in an individual</td>
 +
</tr>
 +
<tr>
 +
<td>Date element Scope</td>
 +
<td>Reactant element of allergy or intolerance record</td>
 +
</tr>
 +
<tr>
 +
<td>Inclusion criteria</td>
 +
<td>Specific or general substances to which a patient may be exposed and which may be suspected of causing an adverse reaction; assertions negating these suspicions</td>
 +
</tr>
 +
<tr>
 +
<td>Exclusion criteria</td>
 +
<td>Actual conditions caused by exposure (reactions, allergies)</td>
 +
</tr>
  
 +
</table>
  
 
===Meeting Outcomes===
 
===Meeting Outcomes===
Line 132: Line 378:
  
 
| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' ''
 
| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' ''
−
* Please review questions
+
* Please review proposed text
−
* Please review ballot outline
 
  
  
Line 148: Line 393:
  
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
−
* Review draft list
+
* Review text
−
* Review draft ballot
+
* Review HTA feedback
 +
* Review overlap findings
 
|}
 
|}
  
 
© 2012 Health Level Seven® International.  All rights reserved.
 
© 2012 Health Level Seven® International.  All rights reserved.

Latest revision as of 00:44, 15 March 2018

R INFORMATION--> Back to Allergy_&_Intolerance_Drug_Sub-project

Meeting Information

HL7 Negation Requirements Meeting Minutes

Location: Phone

Date: 2018-03-14
Time: 5:00-6:00 ET
Facilitator Jay Lyle Note taker(s) Jay Lyle
Attendee Name Affiliation


y Jay Lyle JP Systems / VA
y Russ Leftwich
y Elaine Ayres
y Stephen Chu
y George Dixon
y Sue Kent
y Lindsey Hoggle
y Yanyan Hu

Agenda

Agenda Topics

  1. VSAC text
  2. Publication of ballot document
  3. Maintenance; liaison with CCDA & FHIR

Minutes

Minutes/Conclusions Reached:

  1. We will continue our meetings at the biweekly Wednesday time until the agenda items are resolved.
  2. Re VSAC stewardship: Jay and Elaine to talk to HL7 HTA about appropriate path. This includes maintenance plans.
  3. VSAC text in process. Note guidance from NLM.
  4. Similar value sets are published by other groups. Check for overlap.
  5. publish in VSAC, using roles (2) and text (3) defined above.
  6. Document publication process steps
    1. Jay finish applying changes, circulate document
    2. After VSAC publication publish, include OIDs
  7. FHIR & CCDA adoption
    1. CCDA: Emma, Lisa
    2. FHIR: Michelle


Proposed VSAC definitions

element text
Drug substances - reviewed 3/14
OID NLM-assigned
Name Common Drug Substances for Allergy and Intolerance Documentation
Author
Steward
Clinical focus Documentation of a medication substance commonly suspected of causing an allergy or intolerance reaction in an individual
Date element Scope Reactant element of allergy or intolerance record
Inclusion criteria RxNorm substances of term type ingredient (IN) or multiple ingredient (MIN)
Exclusion criteria Other RxNorm term types
Drug classes - reviewed 3/14
OID NLM-assigned
Name Common drug classes for allergy and intolerance documentation
Author TBD
Steward TBD
Clinical focus Documentation of a class of medication substances suspected of causing an allergy or intolerance reaction in an individual
Date element Scope Reactant element of allergy or intolerance record
Inclusion criteria NDF-RT drug classes commonly relevant to allergy or intolerance cross-reactivity
Exclusion criteria NDF-RT drug classes not commonly relevant to allergy or intolerance cross-reactivity
Foods
OID NLM-assigned
Name Common dietary substances for allergy and intolerance documentation
Author TBD
Steward TBD
Clinical focus Documentation of a class of foods and dietary substances suspected of causing an allergy or intolerance reaction in an individual
Date element Scope Reactant element of allergy or intolerance record
Inclusion criteria SNOMED-CT dietary substances ingested by patients, both specific (e.g., strawberry) and general (e.g., crustaceans); Substances that may be either foods or drugs (e.g., ethanol)
Exclusion criteria SNOMED-CT prodcuts; environmental substances; expressions asserting absence of conditions; Actual conditions caused by exposure (reactions, allergies)
Environmental substances
OID NLM-assigned
Name Common environmental substances for allergy and intolerance documentation
Author TBD
Steward TBD
Clinical focus Documentation of environmental substances to which patients may be exposed suspected of causing an allergy or intolerance reaction in an individual
Date element Scope Reactant element of allergy or intolerance record
Inclusion criteria SNOMED-CT environmental substances suspected of causing reactions
Exclusion criteria Drugs and foods; expressions asserting absence of conditions; Actual conditions caused by exposure (reactions, allergies)
Negations
OID NLM-assigned
Name Common negations of substance causes for allergy for allergy and intolerance documentation
Author TBD
Steward TBD
Clinical focus Refutation of associations between substances and reactions
Date element Scope Reactant element of allergy or intolerance record
Inclusion criteria Assertions that a substance or class of substance does not cause adverse reactions in the patient
Exclusion criteria Substances; Actual conditions caused by exposure (reactions, allergies)
Negations
OID NLM-assigned
Name Common substances for allergy and intolerance documentation
Author TBD
Steward TBD
Clinical focus Documentation of substances suspected of causing an allergy or intolerance reaction in an individual
Date element Scope Reactant element of allergy or intolerance record
Inclusion criteria Specific or general substances to which a patient may be exposed and which may be suspected of causing an adverse reaction
Exclusion criteria Actual conditions caused by exposure (reactions, allergies); negations of these conditions
Negations
OID NLM-assigned
Name Common values for allergy and intolerance documentation
Author TBD
Steward TBD
Clinical focus Documentation of substances suspected of (or not suspected of) causing an allergy or intolerance reaction in an individual
Date element Scope Reactant element of allergy or intolerance record
Inclusion criteria Specific or general substances to which a patient may be exposed and which may be suspected of causing an adverse reaction; assertions negating these suspicions
Exclusion criteria Actual conditions caused by exposure (reactions, allergies)

Meeting Outcomes

Actions
  • Please review proposed text


Next Meeting/Preliminary Agenda Items
  • Review text
  • Review HTA feedback
  • Review overlap findings

© 2012 Health Level Seven® International. All rights reserved.

Retrieved from "https://wiki.hl7.org/w/index.php?title=2018-03-14PC_DrugAllergySubstance_Call_Minutes&oldid=154590"